Lucy R. Yates

Lucy R. Yates

Auto-generated profile, based on publicly available information

Lucy R. Yates

Wellcome Sanger Institute, Hinxton, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2022 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
ZSZaira Seferbekova
Zaira Seferbekova
ALArtem Lomakin
Artem Lomakin
LYLucy R. Yates
Lucy R. Yates
MGMoritz Gerstung
Moritz Gerstung

9 November 2022 in Nature
Verified
Journal Article
Open access
PDF file
ALArtem Lomakin
Artem Lomakin
JSJessica Svedlund
Jessica Svedlund
CSCarina Strell
Carina Strell
MGMilana Gataric
Milana Gataric
ASArtem Shmatko
Artem Shmatko
LYLucy R. Yates
Lucy R. Yates
Genome sequencing of cancers often reveals mosaics of different subclones present in the same tumour1–3. Although these are believed to arise according to the principles of somatic evolution, the exact spatial growth patterns and underlying mechanisms remain elusive4,5. Here, to address this need, we developed a workflow that generates detailed quantitative maps of genetic subclone composition across whole-tumour sections. These provide the basis for studying clonal growth patterns, and the histological characteristics, microanatomy and microenvironmental composition of each clone. The approach rests on whole-genome sequencing, followed by highly multiplexed base-specific in situ sequencing, single-cell resolved transcriptomics and dedicated algorithms to link these layers. Applying the base-specific in situ sequencing workflow to eight tissue sections from two multifocal primary breast cancers revealed intricate subclonal growth patterns that were validated by microdissection. In a case of ductal carcinoma in situ, polyclonal neoplastic expansions occurred at the macroscopic scale but segregated within microanatomical structures. Across the stages of ductal carcinoma in situ, invasive cancer and lymph node metastasis, subclone territories are shown to exhibit distinct transcriptional and histological features and cellular microenvironments. These results provide examples of the benefits afforded by spatial genomics for deciphering the mechanisms underlying cancer evolution and microenvironmental ecology.


16 April 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
ALArtem Lomakin
Artem Lomakin
JSJessica Svedlund
Jessica Svedlund
CSCarina Strell
Carina Strell
MGMilana Gataric
Milana Gataric
ASArtem Shmatko
Artem Shmatko
LYLucy R Yates
Lucy R Yates
Subclonality is a universal feature of cancers yet how clones grow, are spatially organised, differ phenotypically or influence clinical outcome is unclear. To address this, we developed base specific in situ sequencing (BaSISS). In fixed tissues, transcripts harbouring clone-defining mutations are detected, converted into quantitative clone maps and characterised through multi-layered data integration. Applied to 8 samples from key stages of breast cancer progression BaSISS localised 1.42 million genotype informative transcripts across 4.9cm 2 of tissue. Microscopic clonal topographies are shaped by resident tissue architectures. Distinct transcriptional, histological and immunological features distinguish coexistent genetic clones. Spatial lineage tracing temporally orders clone features associated with the emergence of aggressive clinical traits. These results highlight the pivotal role of spatial genomics in deciphering the mechanisms underlying cancer progression.